UCB Celltech

Quick facts

Phase 1 pipeline

• UCB4940
• UCB4940 560 mg
• UCB7665 Intravenous 1
• UCB7665 Intravenous 2
• UCB7665 Intravenous 3
• UCB7665 Intravenous 4
• UCB7665 Intravenous 5
• UCB7665 Subcutaneous 1
• UCB7665 Subcutaneous 2

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• UCB Celltech portfolio CI brief
• UCB Celltech pipeline updates RSS